Matthew Abernethy

Matthew Abernethy

Director of Finance/CFO at NEUROCRINE BIOSCIENCES, INC.

Net worth: 7 M $ as of 31/05/2026

47 year
Health Technology
Consumer Services
Commercial Services

Profile

Matthew C. Abernethy is Chief Financial Officer at Neurocrine Biosciences, Inc. and Vice President-Finance of Biomet Orthopedics LLC. He is also on the board of BIOCOM. Mr. Abernethy previously held the position of Treasurer & Vice President-Investor Relations at Zimmer Biomet Holdings, Inc. Treasurer for Biomet, Inc. and Treasurer for Zimmer US, Inc. (both are subsidiaries of Zimmer Biomet Holdings, Inc.). Mr. Abernethy received an undergraduate degree from Grace College & Seminary and an MBA from The University of Chicago.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
31/03/2026 42,808 ( 0.04% ) 7 M $ 31/05/2026
31/03/2026 0 ( -.--% ) - $ 31/05/2026

Matthew Abernethy active positions

CompaniesPositionStart
NEUROCRINE BIOSCIENCES, INC. Director of Finance/CFO 01/11/2017
DIUL GROUP Director/Board Member 01/11/2022
FATE THERAPEUTICS, INC. Director/Board Member 29/05/2025
SOLENO THERAPEUTICS, INC. Director/Board Member 15/05/2026
Director/Board Member -

Former positions of Matthew Abernethy

CompaniesPositionEnd
ZIMMER BIOMET HOLDINGS, INC. Public Communications Contact 01/11/2017
Investor Relations Contact 01/11/2017
Director of Finance/CFO 01/06/2015
Director/Board Member -
░░░░░░░ ░░░░ ░░░░░░░░░ -
See the detail of Matthew Abernethy's experience

Training of Matthew Abernethy

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

62

1st degree connections

12

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies12

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Commercial Services

Health Technology

Health Technology

Health Technology

Commercial Services

  1. Stock Market
  2. Insiders
  3. Matthew Abernethy
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!